Top Inventors for class "Drug, bio-affecting and body treating compositions" |
Rank | Inventor's name | Country | City/State | Last publication | # of patent apps in this class |
1 | David M. Goldenberg | US | Mendham, NJ | Nov 11, 2021 / 20210346511 - IMMUNOCONJUGATES WITH AN INTRACELLULARLY-CLEAVABLE LINKAGE | 197 |
2 | Hy Si Bui | US | Piscataway, NJ | Dec 30, 2021 / 20210401702 - COSMETIC COMPOSITION PROVIDING UNIQUE SENSATIONS | 108 |
3 | Lowell L. Wood, Jr. | US | Bellevue, WA | Dec 09, 2021 / 20210381772 - TEMPERATURE-CONTROLLED PORTABLE COOLING UNITS | 103 |
4 | Roderick A. Hyde | US | Redmond, WA | Mar 19, 2020 / 20200090805 - MONITORING TREATMENT COMPLIANCE USING PATIENT ACTIVITY PATTERNS | 102 |
5 | Yat Sun Or | US | Watertown, MA | Jan 03, 2019 / 20190002479 - HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS | 92 |
6 | Robert S. Langer | US | Newton, MA | Sep 15, 2022 / 20220287983 - BRANCHED POLY(-AMINO ESTERS) FOR THE DELIVERY OF NUCLEIC ACIDS | 90 |
7 | Chien-Hsing Chang | US | Downingtown, PA | Jun 22, 2017 / 20170173167 - Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments | 89 |
8 | Hans J. Hansen | US | Picayune, MS | Sep 14, 2017 / 20170260287 - Stable Compositions of High-Concentration Allotype-Selected Antibodies for Small-Volume Administration | 85 |
9 | Elizabeth A. Sweeney | US | Seattle, WA | Mar 19, 2020 / 20200090805 - MONITORING TREATMENT COMPLIANCE USING PATIENT ACTIVITY PATTERNS | 72 |
10 | Yan Wu | US | Foster City, CA | Aug 11, 2022 / 20220251213 - Anti-B7-H4 Antibodies and Immunoconjugates | 70 |
11 | Eric C. Leuthardt | US | St. Louis, MO | Mar 19, 2020 / 20200090805 - MONITORING TREATMENT COMPLIANCE USING PATIENT ACTIVITY PATTERNS | 64 |
12 | Tariq Ghayur | US | Holliston, MA | Dec 27, 2018 / 20180369250 - METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS | 63 |
13 | Christian Klein | CH | Bonstetten | Sep 08, 2022 / 20220281995 - ANTI-FAP ANTIBODIES AND METHODS OF USE | 62 |
14 | Mohamed Kanji | US | Edison, NJ | Jul 10, 2014 / 20140194534 - REFRESHING CREAM FOUNDATION IN GEL FORM | 62 |
15 | Neil P. Desai | US | Los Angeles, CA | Jun 22, 2017 / 20170172975 - NANOPARTICLE FORMULATIONS AND USES THEREOF | 57 |
16 | Nicholas V. Perricone | US | Madison, CT | Oct 17, 2019 / 20190314306 - SYSTEMS AND METHODS FOR TREATING VITILIGO | 54 |
17 | Jasbir Seehra | US | Lexington, MA | Sep 22, 2022 / 20220296708 - ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF | 52 |
18 | Yusuke Nakamura | JP | Tokyo | Sep 08, 2022 / 20220283648 - IMAGE DISPLAY APPARATUS AND IMAGE DISPLAY METHOD | 51 |
19 | Stephen D. Pacetti | US | San Jose, CA | Jun 07, 2018 / 20180154051 - Morphology Profiles For Control Of Agent Release Rates From Polymer Matrices | 51 |
20 | Barton F. Haynes | US | Durham, NC | Mar 31, 2022 / 20220096632 - HIV-1 NEUTRALIZING ANTIBODIES AND USES THEREOF | 51 |
21 | Takuya Tsunoda | JP | Kanagawa | Jul 13, 2017 / 20170198010 - TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME | 51 |
22 | Mariagrazia Pizza | IT | Siena | Jun 15, 2017 / 20170165346 - COMBINATION NEISSERIAL COMPOSITIONS | 51 |
23 | Ugur Sahin | DE | Mainz | Sep 15, 2022 / 20220288199 - Therapeutic RNA and Anti-PD1 Antibodies for Advanced Stage Solid Tumor Cancers | 50 |
24 | Edward S. Boyden | US | Cambridge, MA | Apr 07, 2016 / 20160096036 - LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF | 50 |
25 | David B Weiner | US | Merion, PA | Jul 07, 2022 / 20220211845 - DNA ENCODED IL-36 GAMMA AS AN ADJUVANT | 50 |
26 | Leonard G. Presta | US | San Francisco, CA | Aug 25, 2022 / 20220267461 - ANTI-TM4SF1 ANTIBODIES AND METHODS OF USING SAME | 49 |
27 | Jan Poolman | BE | Rixensart | Apr 19, 2018 / 20180104323 - IMMUNOGENIC COMPOSITION | 49 |
28 | Michelle Hines | US | Hickory Creek, TX | Sep 22, 2022 / 20220296496 - TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | 49 |
29 | Robert G. Matheny | US | Norcross, GA | Jul 07, 2022 / 20220211907 - EXTRACELLULAR MATRIX (ECM) STRUCTURES FOR TISSUE REGENERATION | 48 |
30 | Patrick Soon-Shiong | US | Los Angeles, CA | Sep 01, 2022 / 20220273722 - ANTI-EGFR/HIGH AFFINITY NK-CELLS COMPOSITIONS AND METHODS FOR CHORDOMA TREATMENT | 48 |
31 | Vega Masignani | IT | Siena | Jan 06, 2022 / 20220002355 - MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES | 48 |
32 | William F. Mckay | US | Memphis, TN | Jan 03, 2019 / 20190000522 - FILTRATION DEVICE | 48 |
33 | Muriel Y. Ishikawa | US | Livermore, CA | Jan 03, 2019 / 20190001128 - CONTROLLING EAR STIMULATION IN RESPONSE TO ELECTRICAL CONTACT SENSING | 48 |
34 | Austin L. Gurney | US | San Francisco, CA | Jun 30, 2022 / 20220204606 - IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF | 47 |
35 | Tiffany Florence | US | Dallas, TX | Sep 22, 2022 / 20220296496 - TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | 46 |
36 | Sudhir Agrawal | US | Shrewsbury, MA | Sep 08, 2022 / 20220282249 - COMPOUNDS AND METHODS USEFUL FOR MODULATING GENE SPLICING | 46 |
37 | Maria Scarselli | IT | Siena | Aug 18, 2022 / 20220257751 - QUANTIFICATION OF BIOCONJUGATE GLYCOSYLATION | 44 |
38 | David Gan | US | Southlake, TX | Sep 22, 2022 / 20220296496 - TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | 44 |
39 | Paul Parren | NL | Odijk | Aug 11, 2022 / 20220251231 - BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF | 42 |
40 | David L. Kaplan | US | Concord, MA | Sep 22, 2022 / 20220299494 - SYSTEMS AND METHODS FOR HIGH-THROUGHPUT SCREENING AND ANALYSIS OF DRUG DELIVERY SYSTEMS IN VITRO | 42 |
41 | Annick Mercenier | CH | Bussigny | Jun 09, 2016 / 20160158297 - EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS | 42 |
42 | Susan E. Hahn | CA | Toronto | Aug 09, 2012 / 20120201751 - Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44 | 42 |
43 | William J. Mcbride | US | Boonton, NJ | Jun 22, 2017 / 20170173167 - Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments | 41 |
44 | Jerome B. Zeldis | US | Princeton, NJ | Dec 29, 2016 / 20160377621 - METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS | 41 |
45 | Leslie Ann Greene | US | San Diego, CA | Mar 31, 2022 / 20220098327 - COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES | 41 |
46 | Aya Jakobovits | US | Beverly Hills, CA | Aug 27, 2015 / 20150239986 - ANTIBODIES AND MOLECULES DERIVED THEREFROM THAT BIND TO STEAP-1 PROTEINS | 41 |
47 | Toni Weinschenk | DE | Aichwald | Jul 21, 2022 / 20220226450 - NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS | 40 |
48 | Thomas G. Gant | US | Carlsbad, CA | Aug 25, 2022 / 20220267317 - Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 | 40 |
49 | Yao-Ling Qiu | US | Andover, MA | Jan 26, 2017 / 20170022150 - HEPATITIS B ANTIVIRAL AGENTS | 40 |
50 | James R. Baker, Jr. | US | Ann Arbor, MI | Sep 08, 2022 / 20220282657 - ADJUVANT COMPOSITIONS | 40 |
51 | Edmund A. Rossi | US | Woodland Park, NJ | Sep 14, 2017 / 20170260287 - Stable Compositions of High-Concentration Allotype-Selected Antibodies for Small-Volume Administration | 40 |
52 | Helen P. Findlay | CA | Toronto | Aug 09, 2012 / 20120201751 - Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44 | 40 |
53 | Patrick M. Hughes | US | Aliso Viejo, CA | Jan 13, 2022 / 20220008702 - MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT | 39 |
54 | Haichun Huang | US | Fremont, CA | Sep 08, 2022 / 20220281980 - ANTIBODIES AGAINST MICA AND/OR MICB AND USES THEREOF | 39 |
55 | Roberto A. Maldonado | US | Jamaica Plain, MA | Feb 04, 2016 / 20160030555 - TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS | 39 |
56 | Long Pan | US | Cherry Hill, NJ | Apr 21, 2016 / 20160106643 - ANTIPERSPIRANT ACTIVE COMPOSITIONS AND MANUFACTURE THEREOF | 38 |
57 | Takashi Kei Kishimoto | US | Lexington, MA | Mar 10, 2022 / 20220071968 - METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE | 38 |
58 | Pablo Umana | CH | Wollerau | Sep 01, 2022 / 20220275087 - PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES | 38 |
59 | Doron Friedman | IL | Karmei Yosef | Jun 22, 2017 / 20170172857 - FOAMABLE COMPOSITION COMBINING A POLAR SOLVENT AND A HYDROPHOBIC CARRIER | 38 |
60 | Wayne R. Kindsvogel | US | Seattle, WA | Mar 03, 2016 / 20160058914 - Gastrointestinal Device With Associated Microbe-Promoting Agents | 38 |
61 | Tomoyuki Igawa | JP | Shizuoka | Aug 25, 2022 / 20220267822 - METHODS FOR PRODUCING POLYPEPTIDES BY REGULATING POLYPEPTIDE ASSOCIATION | 38 |
62 | Paul Michael Scola | US | Glastonbury, CT | Sep 14, 2017 / 20170260237 - MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS | 37 |
63 | Alla Danilkovitch | US | Columbia, MD | Jun 30, 2022 / 20220202991 - BONE REPAIR PRODUCT AND METHODS OF USE THEREOF | 37 |
64 | Eszter Nagy | AT | Vienna | Dec 02, 2021 / 20210369730 - ANTIVIRAL TREATMENT | 37 |
65 | Meir Eini | IL | Ness Ziona | Jun 22, 2017 / 20170172857 - FOAMABLE COMPOSITION COMBINING A POLAR SOLVENT AND A HYDROPHOBIC CARRIER | 36 |
66 | Pia M. Challita-Eid | US | Encino, CA | Mar 31, 2016 / 20160090411 - NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS | 36 |
67 | John W. Lyga | US | Basking Ridge, NJ | Nov 04, 2021 / 20210338557 - Oxidized Derivatives of GDF-11 Fragments | 36 |
68 | Chung-Ming Hsieh | US | Newton, MA | Sep 15, 2022 / 20220289858 - ANTI-CD40 ANTIBODIES AND USES THEREOF | 36 |
69 | Victoria Smith | US | Burlingame, CA | Jun 22, 2017 / 20170174788 - COMBINATION OF A JAK INHIBITOR AND AN MMP9 BINDING PROTEIN FOR TREATING INFLAMMATORY DISORDERS | 36 |
70 | Özlem Türeci | DE | Mainz | Sep 15, 2022 / 20220288180 - ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES | 36 |
71 | Gerard Zurawski | US | Midlothian, TX | Oct 07, 2021 / 20210308242 - FUSION PROTEINS COMPRISING AN ANTI-CD40 ANTIBODY AND CANCER ANTIGENS | 36 |
72 | Ekkehard Moessner | CH | Kreuzlingen | Sep 08, 2022 / 20220281995 - ANTI-FAP ANTIBODIES AND METHODS OF USE | 36 |
73 | John D. Mendlein | US | Encinitas, CA | Mar 31, 2022 / 20220098568 - HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES | 36 |
74 | Andreas Meinke | AT | Pressbaum | Oct 21, 2021 / 20210322534 - METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3 | 35 |
75 | W. Stephen Hill | US | Ocala, FL | Mar 03, 2016 / 20160058801 - COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND OPTIONALLY REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS | 35 |
76 | John Knopf | US | Carlisle, MA | Sep 22, 2022 / 20220296708 - ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF | 35 |
77 | Fei Hong | US | San Diego, CA | Jun 07, 2018 / 20180155704 - INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF LEUCYL-tRNA SYNTHETASES | 35 |
78 | Michael Prencipe | US | Princeton Junction, NJ | Feb 16, 2017 / 20170042777 - DENTIFRICE CONTAINING ZINC IONS AND POLYPHOSPHATE IONS | 34 |
79 | Kyle P. Chiang | US | Cardiff, CA | Jun 07, 2018 / 20180155704 - INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF LEUCYL-tRNA SYNTHETASES | 34 |
80 | Derek O'Hagan | US | Winchester, MA | Dec 29, 2016 / 20160375132 - HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF | 34 |
81 | Zhe Wang | US | Hockessin, DE | Mar 13, 2014 / 20140073797 - PROCESSES FOR THE PREPARATION OF 2-FLUORO 6-11 BICYCLIC ERYTHROMYCIN DERIVATIVES | 34 |
82 | Stephen E. Zale | US | Hopkinton, MA | Aug 20, 2020 / 20200261596 - Therapeutic Particles with Peptide Boronic Acid or Boronate Ester Compounds and Methods of Making and Using Same | 34 |
83 | Oleg Iliich Epshtein | RU | Moscow | Jul 07, 2022 / 20220213197 - MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES | 34 |
84 | Ravindra Kumar | US | Acton, MA | Sep 22, 2022 / 20220296708 - ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF | 34 |
85 | Susan Daly | US | Basking Ridge, NJ | Sep 08, 2022 / 20220280400 - SUNSCREEN COMPOSITIONS CONTAINING A COMBINATION OF A LINEAR ULTRAVIOLET RADIATION-ABSORBING POLYETHER AND OTHER ULTRAVIOLET-SCREENING COMPOUNDS | 33 |
86 | Paul Polakis | US | Mill Valley, CA | Aug 11, 2022 / 20220251213 - Anti-B7-H4 Antibodies and Immunoconjugates | 33 |
87 | Nicholas J. Papadopoulos | US | Lagrangeville, NY | Dec 09, 2021 / 20210380702 - HUMAN ANTIBODIES TO PD-L1 | 33 |
88 | Gregory I. Frost | US | Del Mar, CA | Feb 25, 2016 / 20160051640 - SOLUBLE GLYCOSAMINOGLYCANASES AND METHODS OF PREPARING AND USING SOLUBLE GLYCOSAMINOGLYCANASES | 33 |
89 | Heinrich Kugelmann | DE | Aachen | Dec 27, 2018 / 20180369235 - CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS | 33 |
90 | John R. Desjarlais | US | Pasadena, CA | Sep 15, 2022 / 20220289839 - HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6 | 33 |
91 | Nathan P. Myhrvold | US | Medina, WA | Mar 19, 2020 / 20200090805 - MONITORING TREATMENT COMPLIANCE USING PATIENT ACTIVITY PATTERNS | 33 |
92 | Arthur B. Raitano | US | Los Angeles, CA | Aug 27, 2015 / 20150239986 - ANTIBODIES AND MOLECULES DERIVED THEREFROM THAT BIND TO STEAP-1 PROTEINS | 33 |
93 | Sachiko Yoshimura | JP | Kanagawa | Jul 13, 2017 / 20170198010 - TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME | 33 |
94 | David S. F. Young | CA | Toronto | Aug 09, 2012 / 20120201751 - Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44 | 33 |
95 | Thorsten Knappe | DE | Schenefeld | Dec 30, 2021 / 20210401360 - HAIR ANALYSING DEVICE | 32 |
96 | Eric Perrier | FR | Les Cotes D'Arey | Jun 15, 2017 / 20170165159 - COSMETIC KIT FOR PROTECTING THE SKIN AGAINST UV RAYS | 32 |
97 | Michael R. Robinson | US | Irvine, CA | Aug 20, 2020 / 20200261358 - BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR THE SUSTAINED RELEASE OF PROTEINS | 32 |
98 | Herren Wu | US | Boyds, MD | Jun 15, 2017 / 20170166630 - HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF | 32 |
99 | Serengulam V. Govindan | US | Summit, NJ | Dec 23, 2021 / 20210395385 - EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY OF TUMORS RELAPSED/REFRACTORY TO CHECKPOINT INHIBITORS | 32 |
100 | Alain Philippe Vasserot | US | Carlsbad, CA | Jul 13, 2017 / 20170198253 - METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS | 32 |